Olanzapine response in treatment-refractory schizophrenic patients with a history of substance abuse

Schizophrenia Research

Volumn 33, Issue 1-2, 1998, Pages 95-101

  Conley, Robert R ^a,b   Kelly, Deanna L ^a,b   Gale, Elizabeth A ^b  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^b Spring Grove Hospital Center   (United States)

Author keywords

Alcohol; Antipsychotic; Illicit drugs; Olanzapine; Substance abuse; Treatment resistant

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; ANAMNESIS; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SUBSTANCE ABUSE; TARDIVE DYSKINESIA;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; HUMANS; MALE; MIDDLE AGED; PIRENZEPINE; SCHIZOPHRENIA; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 0032494208     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(98)00062-0     Document Type: Article

References (28)

1. Alterman, A.I., Ayre, F.R., Williford, W.O., 1984. Diagnostic validation of conjoint schizophrenia and alcoholism. J. Clin. Psychiatry 45, 300-303.
2. Alvir, J.M.J., Lieberman, J.A., Safferman, A.Z. et al., 1993. Clozapine-induced agranulocytosis: incidence and risk factors in the United States. New Engl. J. Med. 329, 162-167.
3. Bailey, L.G., Maxwell, S., Brandabur, M.M., 1997. Substance abuse as a risk factor for tardive dyskinesia: a retrospective analysis of 1027 patients. Psychopharmacol. Bull. 33, 177-181.
4. Barbee, J.G., Clark, P.D., Crapanzano, M.S. et al., 1989. Alcohol and substance abuse among schizophrenic patients presenting to an emergency psychiatric service. J. Nerv. Ment. Dis. 177, 400-407.
5. Beasley, C.M., Tollefson, G., Tran, P. et al., 1996. Olanzapine versus placebo and haloperidol; acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 14, 111-123.
6. Bowers Jr., M.B., Mazure, C.M., Nelson, J.C. et al., 1990. Psychotogenic drug use and neuroleptic response. Schizophr. Bull. 16, 81-85.
7. Brady, K., Anton, R., Ballenger, J.C. et al., 1990. Cocaine abuse among schizophrenic patients. Am. J. Psychiatry 147, 1164-1167.
8. Breakey, W.R., Lorenz, P.C., McHugh, P.R., 1974. Hallucinogenic drugs as precipitant of schizophrenia. Psychol. Med. 4, 255-261.
9. Buckley, P., Thompson, P., Way, L. et al., 1994. Substance abuse among patients with treatment resistant schizophrenia: characteristics and implications for clozapine therapy. Am. J. Psychiatry 151, 385-389.
10. Carpenter, M.D., Mulligan, J.C., Bader, I.A. et al., 1985. Multiple admissions to an urban psychiatric center: a comparative study. Hosp. Community Psychiatry 36, 1305-1308.
11. Cleghorn, J.M., Kaplan, R.D., Szechtman, B. et al., 1991. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive functions. J. Clin. Psychiatry 52, 26-30.
12. Conley, R.R., Tamminga, C.A., Bartko, J. et al., 1998. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia. Am. J. Psychiatry. 155, 914-920.
13. Crowley, T.J., Chesluk, D., Dilts, S., Hart, R., 1974. Drug and alcohol abuse among psychiatric admissions: a multidrug clinical toxicologic study. J. Nerv. Ment. Dis. 30, 13-20.
14. Dixon, L., Haas, G., Weiden, P.J. et al., 1991. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am. J. Psychiatry 148, 224-229.
15. Dixon, L., Dibietz, E., Myers, P. et al., 1993. Comparison of DSM-III-R diagnoses and a brief interview for substance abuse among state hospital patients. Hosp. Community Psychiatry 44, 748-751.
16. Donovan, D.M., Marlatt, D.A. (Eds.), 1988. Assessment of Addictive Behaviors. Guilford Press, New York.
17. Drake, R.E., Osher, F.C., Wallach, M.A., 1989. Alcohol use and abuse in schizophrenia: a prospective community study. J. Nerv. Ment. Dis. 177, 408-414.
18. Duke, P.J., Pantelis, C., Barnes, T.R., 1994. South Westminster schizophrenia study. Alcohol use and its relationship to symptoms, tardive dyskinesia, and illness onset. Br. J. Psychiatry 164, 630-636.
19. Gale, E., Hirsh, K., Kent, D. et al., 1995. Clozapine response in treatment resistant schizophrenics with substance abuse. Schizophr. Res. 15, 150-151.
20. Gupta, S., Hendricks, S., Kenkel, A.M. et al., 1996. Relapse in schizophrenia: is there a relationship to substance abuse? Schizophr. Res. 20, 153-156.
21. Mueser, K.T., Yarnold, P.R., Levinson, D.F. et al., 1990. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr. Bull. 16, 31-53.
22. Perkins, K.A., Simpson, J.C., Tsuang, M.T., 1986. Ten-year follow-up of drug abusers with acute or chronic psychosis. Hosp. Community Psychiatry 37, 481-484.
23. Regier, D.A., Farmer, M.E., Rae, D.S. et al., 1990. Comorbidity of mental disorders with alcohol and other drug use. J. Am. Med. Assoc. 264, 2511-2518.
24. Sevy, S., Kay, S.R., Opler, L.A. et al., 1990. Significance of cocaine history in schizophrenia. J. Nerv. Ment. Dis. 178, 642-648.
25. Tamminga, C.A., Thaker, G.K., Moran, M. et al., 1994. Clozapine in tardive dyskinesia: observations from human and animal model studies. J. Clin. Psychiatry 55 (Suppl. B), 102-106.
26. Tollefson, G.D., Beasley, C.M., Tamura, R.N. et al., 1997. Blind controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine of haloperidol. Am. J. Psychiatry 154, 1248-1254.
27. Wilkins, J.N., Shaner, A.L., Patterson, C.M. et al., 1991. Discrepancies between patient report clinical assessment and urine analysis in psychiatric patients during inpatient admission. Psychopharmacol. Bull. 27, 149-154.
28. Zisook, S., Heaton, R., Moranville, J. et al., 1992. Past substance abuse and clinical course of schizophrenia. Am. J. Psychiatry 149, 552-553.